Results 241 to 250 of about 896,724 (352)

Correction to: Phenotype and multi-omics comparison of Staphylococcus and Streptococcus uncovers pathogenic traits and predicts zoonotic potential

BMC Genomics, 2021
Niels A. Zondervan, Vitor A. P. Martins dos Santos, Maria Suarez-Diez, Edoardo Saccenti   +3 more
doaj   +1 more source

Bayesian design strategies for synthetic biology [PDF]

, 2011
C. Barnes, Daniel Silk, Michael P. H. Stumpf   +2 more
openalex   +1 more source

Correction to: Refactoring of a synthetic raspberry ketone pathway with EcoFlex

Microbial Cell Factories, 2021
Simon J. Moore, Yonek B. Hleba, Sarah Bischoff, David Bell, Karen M. Polizzi, Paul S. Freemont   +5 more
doaj   +1 more source

Synthetic biology: From the first synthetic cell to see its current situation and future development [PDF]

, 2011
LiuYan Zhang, Suhua Chang, Jing Wang
openalex   +1 more source

Preventing Multimer Formation in Commonly Used Synthetic Biology Plasmids. [PDF]

ACS Synth Biol
Vaisbourd E, Bren A, Alon U, Glass DS.
europepmc   +1 more source

BCS1L‐Associated Disease: 5′‐UTR Variant Shifts the Phenotype Towards Axonal Neuropathy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives To investigate the consequences of a pathogenic missense variant (c.838C>T; p.L280F) and a 5′‐UTR regulatory variant (c.‐122G>T) in BCS1L on disease pathogenesis and to understand how regulatory variants influence disease severity and clinical presentation.
Rotem Orbach, Nunziata Maio, Russell J. Butterfield, A. Reghan Foley, Sarah Silverstein, Yan Li, Katherine Chao, Tanya J. Lehky, Abigail Potticary, Tracey A. Rouault, Sandra Donkervoort, Carsten G. Bönnemann   +11 more
wiley   +1 more source

Glial Fibrillary Acidic Protein Astrocytopathy Based on a Two‐Center Chinese Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Glial fibrillary acidic protein astrocytopathy (GFAP‐A) is a recently defined nosological form belonging to the class of autoimmune inflammatory disorders affecting the central nervous system (CNS). Here, we report the clinical and MRI characteristics, treatment, and prognosis of a GFAP‐A cohort from two centers in China.
Ti Wu, Hao Zhang, Chao Gao, Qiuhua Yu, Moli Fan, Lin‐Jie Zhang, Haipeng Zhang, Hengri Cong, Yuzhen Wei, Chotima Böttcher, Alexej Verkhratsky, Friedemann Paul, Fu‐Dong Shi, Tian Song   +13 more
wiley   +1 more source

Challenges in observing transcription-translation for bottom-up synthetic biology. [PDF]

QRB Discov
Bogatyr VG, Wuite GJL.
europepmc   +1 more source

Placebo Effect Sizes in Clinical Trials of Knee Osteoarthritis Using Intra‐Articular Injections of Biologic Agents

Arthritis Care &Research, EarlyView.
Objective Patients with knee osteoarthritis rely on symptomatic treatments, in which up to 75% of the pain reduction can be attributed to the placebo effect. This effect may vary based on treatment type (eg, biologics vs nonbiologic injection) and route of administration (eg, intra‐articular vs topical vs oral).
Johanna M. Borst, Severin Ruoss, Ian Palmer, Trevor Smith, Kenneth Kalunian, Samuel R. Ward   +5 more
wiley   +1 more source

DNA synthesis, assembly and applications in synthetic biology [PDF]

, 2012
Siying Ma, Nicholas Tang, Jingdong Tian
openalex   +1 more source